Format
Sort by
Items per page

Send to

Choose Destination

Best matches for gastric cancer:

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Karimi P et al. Cancer Epidemiol Biomarkers Prev. (2014)

HER2-positive gastric cancer. Boku N et al. Gastric Cancer. (2014)

Current issues and future perspectives of gastric cancer screening. Hamashima C et al. World J Gastroenterol. (2014)

Search results

Items: 1 to 20 of 125921

1.

Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances.

Pirog EC, Park KJ, Kiyokawa T, Zhang X, Chen W, Jenkins D, Quint W.

Adv Anat Pathol. 2018 Sep 18. doi: 10.1097/PAP.0000000000000216. [Epub ahead of print]

PMID:
30234500
2.

MicroRNA-744 promotes cell apoptosis via targeting B cell lymphoma-2 in gastric cancer cell line SGC-7901.

Liu J, Wei Y, Li S, Li Y, Liu H, Liu J, Zhu X.

Exp Ther Med. 2018 Oct;16(4):3611-3616. doi: 10.3892/etm.2018.6602. Epub 2018 Aug 13.

PMID:
30233716
3.

Mixed lineage kinase-4 promotes gastric carcinoma tumorigenesis through suppression of the c-Jun N-terminal kinase signaling pathway.

Xi Y, Niu J, Li D, He J, Qin L, Peng X.

Exp Ther Med. 2018 Oct;16(4):3317-3324. doi: 10.3892/etm.2018.6618. Epub 2018 Aug 20.

PMID:
30233678
4.

Non-random distribution of gastric cancer susceptible loci on human chromosomes.

Mahjoub G, Saadat M.

EXCLI J. 2018 Aug 17;17:802-807. doi: 10.17179/excli2018-1425. eCollection 2018. No abstract available.

PMID:
30233279
5.

Gastric metastasis of ovarian serous cystadenocarcinoma.

Yang S.

Int Med Case Rep J. 2018 Sep 5;11:201-204. doi: 10.2147/IMCRJ.S171985. eCollection 2018.

PMID:
30233254
6.

Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study.

Kharazmi E, Babaei M, Fallah M, Chen T, Sundquist K, Hemminki K.

Clin Epidemiol. 2018 Sep 4;10:1169-1179. doi: 10.2147/CLEP.S168152. eCollection 2018.

PMID:
30233251
8.

Winged Partially Covered Self-Expandable Metal Stent to Prevent Distal Migration in Malignant Gastric Outlet Obstruction.

Choi YK, Ahn JY, Na HK, Jung KW, Kim DH, Lee JH, Choi KD, Song HJ, Lee GH, Jung HY.

Dig Dis Sci. 2018 Sep 19. doi: 10.1007/s10620-018-5284-0. [Epub ahead of print]

PMID:
30232635
9.

Crushed dolutegravir/abacavir/lamivudine given via nasogastric tube in gastric outlet obstruction caused by cancer resulted in rapid viral load suppression.

Chrdle A, Jerhotová Z, Vacík M, Linka M, Chmelík V.

Int J STD AIDS. 2018 Sep 19:956462418797847. doi: 10.1177/0956462418797847. [Epub ahead of print]

PMID:
30231834
10.

What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?

De Mello RA, Castelo-Branco L, Castelo-Branco P, Pozza DH, Vermeulen L, Palacio S, Salzberg M, Lockhart AC.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):249-261. doi: 10.1200/EDBK_198805.

PMID:
30231398
11.

Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.

Wanvimonsuk S, Thitiwanichpiwong P, Keelawat S, Mutirangura A, Kitkumthorn N.

J Med Virol. 2018 Sep 19. doi: 10.1002/jmv.25318. [Epub ahead of print]

PMID:
30229949
12.

Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.

Shi YX, Ye BL, Hu BR, Ruan XJ.

Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5525-5530. doi: 10.26355/eurrev_201809_15813.

PMID:
30229824
13.

The SNORA21 expression is upregulated and acts as a novel independent indicator in human gastric cancer prognosis.

Liu CX, Qiao XJ, Xing ZW, Hou MX.

Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5519-5524. doi: 10.26355/eurrev_201809_15812.

PMID:
30229823
14.

The clinical observation of verapamil in combination with interventional chemotherapy in advanced gastric cancer.

Fan GF, Pan JJ, Fan PS, Zhang TY, Liu YB, Huang J, Weng CT, Liu M, Duan QH, Wu Y, Tang LL, Yang GH, Dai HB, Zhu ZQ.

Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5508-5518. doi: 10.26355/eurrev_201809_15811.

PMID:
30229822
15.

Surgical and Long-Term Survival Outcomes After Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.

Li Z, Liu Y, Bai B, Yu D, Lian B, Zhao Q.

World J Surg. 2018 Sep 18. doi: 10.1007/s00268-018-4799-z. [Epub ahead of print]

PMID:
30229383
16.

Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component.

Yamada R, Horiguchi SI, Onishi T, Motoi T, Hishima T.

Case Rep Pathol. 2018 Aug 28;2018:3620293. doi: 10.1155/2018/3620293. eCollection 2018.

17.

Giant gastric ulcers: Malignancy yield and predictors from a 10-year retrospective single centre cohort.

Lord R, El-Feki M, Tomos L, Mohammed N, Subramanian V, Rembacken BJ.

United European Gastroenterol J. 2018 Aug;6(7):1000-1006. doi: 10.1177/2050640618770013. Epub 2018 Apr 13.

PMID:
30228887
18.

Recent advances in the management of gastric adenocarcinoma patients.

Harada K, Lopez A, Shanbhag N, Badgwell B, Baba H, Ajani J.

F1000Res. 2018 Aug 30;7. pii: F1000 Faculty Rev-1365. doi: 10.12688/f1000research.15133.1. eCollection 2018. Review.

19.

Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer.

Lin JX, Xie XS, Weng XF, Zheng CH, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Li P, Huang CM.

World J Gastroenterol. 2018 Sep 14;24(34):3898-3907. doi: 10.3748/wjg.v24.i34.3898.

20.

Supplemental Content

Loading ...
Support Center